Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

ReoPro effective in baboon models of human renal disorders

July 11, 1997

Factor Xa inhibitors from Berlex

July 11, 1997

Outcome in unstable angina improved with ReoPro

July 8, 1997

Novel antiplatelet agent from Cypress Bioscience

July 4, 1997

Effects of thrombin inhibitor with or without gpIIb/IIIa antagonist during coronary thrombolysis

July 3, 1997

Topical t-PA for the treatment of venous ulcers

July 2, 1997

Synthesis and pharmacological profile of new antithrombotic pentasaccharide

July 2, 1997

Cell Genesys reports encouraging preclinical results of gene therapy for hemophilia

July 1, 1997

ReoPro safe and effective in high-risk PTCA patients

July 1, 1997

Modified t-PA from Eisai highly effective thrombolytic

July 1, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.